Navigation Links
Carbon nanotubes boost cancer-fighting cells
Date:4/20/2010

New Haven, Conn.Yale University engineers have found that the defects in carbon nanotubes cause T cell antigens to cluster in the blood and stimulate the body's natural immune response. Their findings, which appear as the cover article of the April 20 issue of the journal Langmuir, could improve current adoptive immunotherapy, a treatment used to boost the body's ability to fight cancer.

Adoptive immunotherapy involves extracting a patient's blood so that the number of naturally occurring T cells (a type of white blood cell) can reproduce more effectively in the laboratory. Although the body produces its own tumor-fighting T cells, they are often suppressed by the tumor and are too few to be effective. Scientists boost the production of T cells outside the body using different substances that encourage T cell antigens to cluster in high concentrations. The better these substances are at clustering T cell antigens, the greater the immune cell proliferation. Once enough T cells are produced, the blood is transferred back into the patient's body.

The Yale team had previously reported the unexpected effect that carbon nanotubes had on T cell production. They found that the antigens, when presented on the surface of the nanotubes, stimulated T cell response far more effectively than coating other substrates such as polystyrene in the antigens, even though the total amount of antigens used remained the same.

Now they have discovered the reason behind the increased stimulation. They found that the antigens cluster in high concentrations around the tiny defects found in the carbon nanotubes.

"Carbon nanotube bundles resemble a lymph node microenvironment, which has a labyrinth sort of geometry," said Tarek Fahmy, associate professor of chemical engineering and biomedical engineering at Yale and senior author of the paper. "The nanotube bundles seem to mimic the physiology and adsorb more antigens, promoting a greater immunological response."

Current adoptive immunotherapy takes weeks to produce enough T cells, but lab tests showed that the nanotubes produced the same T cell concentration in just one-third the time, Fahmy said.

Carbon nanotubes can cause problems, such as an embolism, when used in the body. But this isn't the case when they are used in blood that has been extracted from the patient, Fahmy said. Next, the team will work on a way to effectively remove the carbon nanotubes from the blood before it is returned to the patient.

"We think this is a really interesting use of carbon nanotubes. It's a way to exploit the unique properties of this material for biological application in a safe way."


'/>"/>

Contact: Suzanne Taylor Muzzin
suzanne.taylormuzzin@yale.edu
203-432-8555
Yale University
Source:Eurekalert

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Mice use specialized neurons to detect carbon dioxide in the air
3. Researchers find new taste in fruit flies: carbonated water
4. Studying component parts of living cells with carbon nanotube cellular probes
5. New membrane strips carbon dioxide from natural gas faster and better
6. Green alga genome project catalogs carbon capture machinery
7. Hungry microbes share out the carbon in the roots of plants
8. Decline in uptake of carbon emissions confirmed
9. Study reveals that nitrogen fertilizers deplete soil organic carbon
10. US fires release large amounts of carbon dioxide
11. Wildfire drives carbon levels in northern forests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology: